Beauty ingredient · Antioxidant
BHA (butylated hydroxyanisole)
- CAS
- 25013-16-5
A synthetic antioxidant used in some lipsticks and creams.
- Preservative
- Expert review pending
Concern level
A regulatory warning or restriction somewhere, or strong evidence of harm at typical intake. The concern level sets how many points BHA (butylated hydroxyanisole) costs on a product’s receipt.
What the evidence says
-
Warning label requiredRegulatory
Listed under California Proposition 65 (cancer, 1990); IARC Group 2B; the US NTP lists it as reasonably anticipated to be a human carcinogen. [1][2][3]
Evidence tiers say how sure the evidence is, separately from how much it matters. About evidence tiers.
Rules around the world
| Where | Status | Details | Date | Source |
|---|---|---|---|---|
| California (US) | Warning label required | Listed under Proposition 65 (cancer, 1990). | Jan 1, 1990 | [1] |
“Banned” means explicitly prohibited or withdrawn after review; “not permitted” means never authorized there. We use each regulator’s own words.
Names GoodSwap recognizes on labels (4)
- bha
- butylated hydroxyanisol
- butylated hydroxyanisole
- bha butylated hydroxyanisole
Sources
-
Proposition 65 List of Chemicals Known to the State to Cause Cancer or Reproductive Toxicity
“The date refers to the initial appearance of the chemical on the list.”
oehha.ca.gov
-
Agents Classified by the IARC Monographs, Volumes 1–142 (List of Classifications)
monographs.iarc.who.int
-
Report on Carcinogens, 15th Edition: Butylated Hydroxyanisole
“Butylated hydroxyanisole (BHA) is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.”
ntp.niehs.nih.gov